Radiopharmaceuticals Market Intelligence Report - Global Forecast to 2027

Radiopharmaceuticals Market Intelligence Report - Global Forecast to 2027

The Global Radiopharmaceuticals Market is projected to reach USD 6,610.33 million by 2027 from USD 4,569.80 million in 2021, at a CAGR 6.34% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Radiopharmaceuticals Market size was estimated at USD 1,606.75 million in 2021 and expected to reach USD 1,682.78 million in 2022, at a CAGR 5.86% to reach USD 2,262.44 million by 2027.
• The Asia-Pacific Radiopharmaceuticals Market size was estimated at USD 1,356.25 million in 2021 and expected to reach USD 1,464.13 million in 2022, at a CAGR 6.92% to reach USD 2,026.94 million by 2027.
• The Europe, Middle East & Africa Radiopharmaceuticals Market size was estimated at USD 1,606.78 million in 2021 and expected to reach USD 1,704.60 million in 2022, at a CAGR 6.32% to reach USD 2,320.94 million by 2027.

Market Segmentation & Coverage:

The report on radiopharmaceuticals identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the radiopharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• Diagnostic Nuclear Medicine
  • Pet Radiopharmaceuticals
    • F-18
    • Ru-82
  • Spect Radiopharmaceuticals
    • Ga-67
    • I-123
    • Tc-99m
    • Tl-201
• Therapeutic Nuclear Medicine
  • Alpha Emitters
  • Beta Emitters
    • I-131
    • Lu-177
    • Re-186
    • Sm-153
    • Y-90
  • Brachytherapy Isotopes
    • Cs-131
    • I-125
    • Ir-192
    • Pd-103

Procedural Volume:

• Diagnostic Procedures
  • Pet Radiopharmaceutical Procedure
  • Spect Radiopharmaceuticals Procedure
• Therapeutic Procedures
  • Alpha Emitter Procedure
  • Beta Emitters Procedure
  • Brachytherapy Isotopes Procedure

Application:

• Diagnostic Applications
  • Pet Applications
    • Cardiology Indication
    • Neurology Indication
    • Oncology Indication
  • Spect Applications
    • Cardiology
    • Lymphoma
    • Neurology
    • Thyroid
• Therapeutic Applications
  • Bone Metastasis
  • Endocrine Tumors
  • Lymphoma Therapeutic
  • Thyroid Therapeutic

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Alliance Holdings Medical Limited
• Bayer AG
• Beijing International Pharmaceutical Technology Co., Ltd.
• Bracco Group
• Cardinal Health, Inc.
• Clarity Pharmaceuticals
• Curium Pharma
• Eckert & Ziegler Group
• Eczacibasi-Monrol Nuclear Products Co.
• Fusion Pharmaceuticals Inc.
• GE Healthcare
• Global Medical Solutions, LTD.
• Institute of Isotopes Co., LTD.
• IsoTherapeutics Group, LLC
• Isotopia Molecular Imaging Ltd.
• Jubilant Pharma Holdings Inc.
• Lantheus Medical Imaging, Inc.
• Mallinckrodt PLC
• Navidea Biopharmaceuticals, Inc.
• Northstar Medical Technologies LLC
• Novartis AG
• NTP Radioisotopes SOC Ltd.
• PharmaLogic Holdings LLC
• SHINE Medical Technologies
• Siemens Healthineers AG
• Sotera Health Holdings, LLC
• State Atomic Energy Corporation Rosatom

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 4,569.80 million

Estimated Year Value: USD 4,851.52 million

Forecast Year Value: USD 6,610.33 million

CAGR (%): 6.34%.

Please Note: PDF & Excel + Online Access - 1 Year